None
Quote | GammaCan International Inc. (OTCMKTS:GCAN)
Last: | $0.0006 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0006 |
Close: | $0.0006 |
High: | $0.0007 |
Low: | $0.0006 |
Volume: | 82,000 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | GammaCan International Inc. (OTCMKTS:GCAN)
BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics and consumer products today announced that it has comp...
BALTIMORE, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that the Company and its scien...
Message Board Posts | GammaCan International Inc. (OTCMKTS:GCAN)
Subject | By | Source | When |
---|---|---|---|
Great. Youre still here. Good post. Thank you | robtewms | investorshub | 07/05/2023 1:52:35 PM |
https://www.globenewswire.com/news-release/2023/07/05/2699515/0/en/GCANRx-Announ | 29YEARINVESTOR | investorshub | 07/05/2023 1:51:23 PM |
I snooze I lose | Backstabbed | investorshub | 07/05/2023 1:42:12 PM |
Right? One wonders whats next for HODLers. | robtewms | investorshub | 07/05/2023 3:13:32 AM |
This is the most posts we have seen | Sheepdog | investorshub | 07/05/2023 12:42:25 AM |
News, Short Squeeze, Breakout and More Instantly...
GammaCan International Inc. Company Name:
GCAN Stock Symbol:
OTCMKTS Market:
BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics and consumer products today announced that it has comp...
BALTIMORE, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that the Company and its scien...
BALTIMORE, July 05, 2023 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that it has been granted fina...